1-9 of 9
Irmela Sulzer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acquired intracoronary ADAMTS13 deficiency and VWF retention at sites of critical coronary stenosis in patients with STEMI

Clinical Trials & Observations
Giovanni Pedrazzini, Luigi Biasco, Irmela Sulzer, Adriana Anesini, Tiziano Moccetti, Johanna A. Kremer Hovinga, Lorenzo Alberio
Journal: Blood
Blood (2016) 127 (23): 2934–2936.
https://doi.org/10.1182/blood-2015-12-688010
Published: 2016
Journal Articles

Anti-Idiotypic-Designed-Ankyrin-Repeat-Molecules (DARPins) Universally Neutralize Plasma-Derived Autoantibodies in Acquired TTP Patients

Monica M Schaller, Asst Prof, PhD, Monique Vogel, PhD, Magdalena Skowronska, PhDstudent, Irmela Sulzer, Johanna A. Kremer Hovinga Strebel, Prof, MD
Journal: Blood
Blood (2015) 126 (23): 104.
https://doi.org/10.1182/blood.V126.23.104.104
Published: 2015
Journal Articles

High-Throughput Screening of a Large Combinatorial Library of Small Proteins Against Human Spleen-Derived Monoclonal Anti-ADAMTS13 Antibodies Yields Specific Anti-Idiotypic Molecules – Potential Tools for New Treatment Strategy in Acquired TTP

Monica Schaller, PhD, Sabine Hiltbrunner, Irmela Sulzer, Monique Vogel, PhD, Karim Kentouche, MD, Bernhard Laemmle, MD, Johanna A. Kremer Hovinga
Journal: Blood
Blood (2012) 120 (21): 487.
https://doi.org/10.1182/blood.V120.21.487.487
Published: 2012
Journal Articles

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy in Acquired TTP Is the Expression of a General Dysregulation of the Immune Response,

Monica Schaller, PhD, Irmela Sulzer, Magnus Mansouri, MD student, Bernhard Lämmle, MD, Johanna A. Kremer Hovinga Strebel, MD
Journal: Blood
Blood (2011) 118 (21): 3299.
https://doi.org/10.1182/blood.V118.21.3299.3299
Published: 2011
Journal Articles

Inhibitory Spleen-Derived Anti-ADAMTS13 Antibodies Are Characterized by a Limited Number of Variable Heavy Chain CDR3 Signatures in Patients with Relapsing Acquired Thrombotic Thromobocytopenic Purpura

Monica Schaller, PhD, Gianna Tanno, Irmela Sulzer, Monique Vogel, PhD, Karim Kentouche, MD, Bernhard Laemmle, MD, Johanna A. Kremer Hovinga Strebel, MD
Journal: Blood
Blood (2011) 118 (21): 194.
https://doi.org/10.1182/blood.V118.21.194.194
Published: 2011
Journal Articles

Restricted Immunglobulin Gene Usage of Spleen-Derived Specific Anti-ADAMTS13 B-Cells In Relapsing TTP Treated with or without Rituximab.

Monica M. Schaller Tschan, PhD, Karin Sprecher, Master, Irmela Sulzer, technician, Monique Vogel, PhD, Beda Stadler, Prof, Karim Kentouche, MD, Bernhard Lämmle, Prof, Johanna A. Kremer Hovinga Strebel, MD
Journal: Blood
Blood (2010) 116 (21): 1431.
https://doi.org/10.1182/blood.V116.21.1431.1431
Published: 2010
Journal Articles

Values for ADAMTS-13 Activity, Antigen and Autoantibodies in Normal European Controls.

Sabine Geiter, Markus Graf, Elin Tschokert, Agnes Veyradier, Martine Wolf, Claudine Caron, Roberta Palla, PhD, Flora Peyvandi, MD, PhD, Johanna A Kremer Hovinga, MD, Irmela Sulzer, Helga Vetr, PhD
Journal: Blood
Blood (2009) 114 (22): 4199.
https://doi.org/10.1182/blood.V114.22.4199.4199
Published: 2009
Journal Articles

A Pathophysiological Role for ADAMTS13 in Thrombotic Thrombocytopenic Purpura (TTP) without Severe ADAMTS13 Deficiency.

Johanna A. Kremer Hovinga, MD, James N. George, MD, Sara K. Vesely, PhD, Deirdre R. Terrell, MPH, Ulrich Budde, MD, Irmela Sulzer, Bernhard Lammle, MD
Journal: Blood
Blood (2006) 108 (11): 1068.
https://doi.org/10.1182/blood.V108.11.1068.1068
Published: 2006
Journal Articles

Factor V Leiden Is Not a Risk Factor for Thrombotic Microangiopathies without Severe ADAMTS13 Deficiency.

Johanna A. Kremer Hovinga, MD, Soraya Krieg, MD, Jan-Dirk Studt, MD, Irmela Sulzer, Bernhard Lammle, MD
Journal: Blood
Blood (2004) 104 (11): 850.
https://doi.org/10.1182/blood.V104.11.850.850
Published: 2004